Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. (Q42225343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Roberto Mario Scarpa

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Carlo Terrone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Francesco Porpiglia

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Berruti A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Tucci M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Tarabuzzi R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gorzegno G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Vana F

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Lamanna G

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Tampellini M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Angeli A

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Dogliotti L

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

English

0 references

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

633-638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602767

8 January 2020

exact match

0 references

cites work

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

State-of-the-art treatment of metastatic hormone-refractory prostate cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Metastasis to bone: causes, consequences and therapeutic opportunities

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Estimating relative survival of Italian cancer patients from sparse cancer registries data

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Management of treatment-related osteoporosis in men with prostate cancer

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361623

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

17 August 2018

1 reference

12 December 2020

A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma

1 reference

12 December 2020

Skeletal fractures negatively correlate with overall survival in men with prostate cancer

1 reference

12 December 2020

Costs of prostate cancer, metastatic to the bone, in the Netherlands

1 reference

12 December 2020

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16222309%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference